162 related articles for article (PubMed ID: 10667130)
1. [Myelomatosis and low level of vitamin B12].
Heyerdahl F; Kildahl-Andersen O
Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4321-2. PubMed ID: 10667130
[TBL] [Abstract][Full Text] [Related]
2. Low cobalamin (vitamin B12) levels in multiple myeloma: a retrospective study.
Vlasveld LT
Neth J Med; 2003 Aug; 61(8):249-52. PubMed ID: 14628959
[TBL] [Abstract][Full Text] [Related]
3. [Vitamin B12 deficiency in geriatrics].
Bopp-Kistler I; Rüegger-Frey B; Grob D; Six P
Praxis (Bern 1994); 1999 Nov; 88(45):1867-75. PubMed ID: 10589285
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum cobalamin in multiple myeloma without signs of vitamin B12 deficiency. A preliminary report.
Hippe E; Hansen OP; Drivsholm A
Scand J Gastroenterol Suppl; 1974; 29():85-7. PubMed ID: 4610725
[No Abstract] [Full Text] [Related]
5. Vitamin B12 metabolism in myelomatosis.
Hansen OP; Drivsholm A; Hippe E
Scand J Haematol; 1977 May; 18(5):395-402. PubMed ID: 877515
[TBL] [Abstract][Full Text] [Related]
6. Additional predictive value of serum unsaturated vitamin B12 proteins in multiple myeloma.
Arnalich F; Zamorano AF; Martinez-Hernández P; Pena JM; Barbado FJ; Vázquez JJ
J Med; 1990; 21(5):277-86. PubMed ID: 2079617
[TBL] [Abstract][Full Text] [Related]
7. Rapid evolution of multiple myeloma after cobalamin therapy for megaloblastic erythropoiesis with macrocytic anemia.
Schleinitz N; Costello R; Veit V; Swiader L; Harle JR; Bouabdallah R; Sainty D; Gastaut JA; Weiller PJ
Leuk Res; 1998 Mar; 22(3):287. PubMed ID: 9619920
[No Abstract] [Full Text] [Related]
8. Megaloblastic anaemia: prevalence and causative factors.
Khanduri U; Sharma A
Natl Med J India; 2007; 20(4):172-5. PubMed ID: 18085121
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric manifestations of vitamin B12 deficiency: a case report].
Durand C; Mary S; Brazo P; Dollfus S
Encephale; 2003; 29(6):560-5. PubMed ID: 15029091
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
Anderson KC; Palumbo A;
Oncology (Williston Park); 2005 Apr; 19(4):447-50. PubMed ID: 15934516
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
[No Abstract] [Full Text] [Related]
13. [Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].
Ikeda H; Hayashi T; Nojima M; Yasui H; Ikeda Y; Ishida T; Adachi M; Imai K
Rinsho Ketsueki; 2005 Apr; 46(4):269-73. PubMed ID: 16444959
[TBL] [Abstract][Full Text] [Related]
14. Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease.
Serefhanoglu S; Aydogdu I; Kekilli E; Ilhan A; Kuku I
Ann Hematol; 2008 May; 87(5):391-5. PubMed ID: 17992530
[TBL] [Abstract][Full Text] [Related]
15. Megaloblastic marrow in macrocytic anaemias at Kenyatta National and M P Shah Hospitals, Nairobi.
Mwanda OW; Dave P
East Afr Med J; 1999 Nov; 76(11):610-4. PubMed ID: 10734519
[TBL] [Abstract][Full Text] [Related]
16. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
Dasanu CA; Alexandrescu DT
Eur J Haematol; 2009 Mar; 82(3):231-4. PubMed ID: 19018868
[TBL] [Abstract][Full Text] [Related]
17. Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment.
Andrès E; Affenberger S; Vinzio S; Kurtz JE; Noel E; Kaltenbach G; Maloisel F; Schlienger JL; Blicklé JF
Am J Med; 2005 Oct; 118(10):1154-9. PubMed ID: 16194648
[TBL] [Abstract][Full Text] [Related]
18. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
19. Hematological response to short-term oral cyanocobalamin therapy for the treatment of cobalamin deficiencies in elderly patients.
Andrès E; Kaltenbach G; Noblet-Dick M; Noel E; Vinzio S; Perrin AE; Berthel M; Blicklé JF
J Nutr Health Aging; 2006; 10(1):3-6. PubMed ID: 16453051
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
